Rhythm Pharmaceuticals SEC filings

Filter: All · 8-K · 10-Q · 10-K · Form 4

10-QNov. 3, 2026, 4:08 p.m. ETView on SEC.gov
8-KNov. 3, 2026, 8:10 a.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits
AI summary, unreviewedRhythm Pharmaceuticals Q3 2026 net product revenue rises to $92.1 million, beating $84.6 million consensus; GAAP EPS $(0.61) beats $(0.74) estimate
SCHEDULE 13GOct. 13, 2026, 1:37 p.m. ETView on SEC.gov
4Sept. 14, 2026, 7:37 p.m. ETView on SEC.gov
4Sept. 1, 2026, 4:22 p.m. ETView on SEC.gov
4Aug. 18, 2026, 5:35 p.m. ETView on SEC.gov
4Aug. 17, 2026, 6 p.m. ETView on SEC.gov
4Aug. 17, 2026, 5:57 p.m. ETView on SEC.gov
4Aug. 14, 2026, 7:04 p.m. ETView on SEC.gov
4Aug. 14, 2026, 7:01 p.m. ETView on SEC.gov
10-QAug. 4, 2026, 4:05 p.m. ETView on SEC.gov
8-KAug. 4, 2026, 7:49 a.m. ETView on SEC.gov
Results of operations and financial condition · Regulation FD disclosure · Other events · Financial statements and exhibits